Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus. - Test2 - elhamkhani - TriplyDB

Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus.

Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus.

http://www.wikidata.org/entity/Q37728750

about

Whole Transcriptome Analysis of Notochord-Derived Cells during Embryonic Formation of the Nucleus Pulposus.Notochordal-cell derived extracellular vesicles exert regenerative effects on canine and human nucleus pulposus cells.Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside.Inhibitory Effects of Human Primary Intervertebral Disc Cells on Human Primary Osteoblasts in a Co-Culture System.Human notochordal cell transcriptome unveils potential regulators of cell function in the developing intervertebral disc CCN family member 2/connective tissue growth factor (CCN2/CTGF) is regulated by Wnt-β-catenin signaling in nucleus pulposus cells NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease

P2860

Q41621230-B24004BD-297B-4DBC-BCEF-9F2C41C1C103 Q47108660-2B31385E-BCB4-4B09-A529-BFB413FF4651 Q55035190-4FD7B701-5A88-4B67-BC6E-5CFBEABB5B5F Q55399009-4ED56C32-C762-45E5-9738-983C86D0D9C1 Q58701338-AFFFF87C-2CD0-44E5-8763-881AF8C53C62 Q58795684-59420E68-E531-4DAC-AE2B-C9089AB08C06 Q59136098-A4C585D2-3685-45D1-B575-450949FAA082

P2860

Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus.

http://www.wikidata.org/entity/Q37728750

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@en

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@nl

type

label

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@en

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@nl

prefLabel

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@en

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@nl

P1433

Q37728750-A81C6A26-74AA-4FD5-82B9-D7DCB4DD0BC2

P1476

Q37728750-9037E878-C19C-4510-97CC-452C0F9F99BA

P2093

Q37728750-3A12A2E2-2DEC-4238-A731-394946E28A72

Q37728750-60204D3C-EA8D-47AE-9DA7-81A8A8F8F695

Q37728750-A3908C15-91E0-4617-9448-F63749A972E9

Q37728750-C81BF755-235F-49C5-A12D-E502DC8635E1

P2860

Q37728750-08E150A0-36AD-43AB-BFE6-57519485C0B7

Q37728750-0BFA9E8D-5C8C-4BDA-9FC8-9B0E5EDCE7DA

Q37728750-0E8A5F47-2365-4A89-AC7B-D395ECE07EE8

Q37728750-16E458F8-D942-410A-B6EE-C2EBCA850E52

Q37728750-1C4DDD79-724E-487C-9F08-1066F2E6FAB9

Q37728750-1C4EE995-9AB8-485B-A267-36FE5F8D56C0

Q37728750-22215761-D7B7-4B8C-96E3-E8769F47358B

Q37728750-2481BA72-2447-49D9-BDBB-61C691977D23

Q37728750-26F3C8A2-3A64-46AF-B6FA-4AF736F4C867

Q37728750-28503D94-370D-4327-93F0-313F83CA12C0

P2888

Q37728750-921BD380-426E-43C7-903C-BCDFE675DE70

P304

Q37728750-5B970546-C493-40D9-ADDB-015F58B35B3B

P31

Q37728750-C4EC9678-DDB1-44DA-A3B8-A363F12D3943

P356

Q37728750-59DC6A8E-A4E7-48F8-9A6B-7B0FB2823A41

P407

Q37728750-50D5785C-4DC0-4728-A81E-61AB5C9BD9BC

P478

Q37728750-C750A64C-A115-4858-8650-195B74BAA030

P577

Q37728750-B5E05852-381F-41C8-B169-A894FFB30A2C

P698

Q37728750-2087D227-98C4-4068-BC4E-42FF5399B2E3

P932

Q37728750-5424F75B-F22E-4EBF-8017-987A0E41B321

P356

P1433

Scientific Reports

P1476

Molecular Therapy for Degenera ...... al Cell-Rich Nucleus Pulposus.

@en

P2093

Ajay Matta

http://www.w3.org/2001/XMLSchema#string

David E Isenman

http://www.w3.org/2001/XMLSchema#string

M Zia Karim

http://www.w3.org/2001/XMLSchema#string

W Mark Erwin

http://www.w3.org/2001/XMLSchema#string

P2860

EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells

Role of cytokines in intervertebral disc degeneration: pain and disc content

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells

BMP antagonists: their roles in development and involvement in pathophysiology

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue

Impaired intervertebral disc development and premature disc degeneration in mice with notochord-specific deletion of CCN2

The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors.

Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling

P2888

P304

45623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP45623

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28358123

http://www.w3.org/2001/XMLSchema#string

P932

5372366

http://www.w3.org/2001/XMLSchema#string